Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 122, Issue 13
September 26 2013
Issue Cover

Table of Contents

INSIDE BLOOD

VASCULAR BIOLOGY
Protective role of the lymphatics from sepsis
Young-Kwon Hong
View Articletitled, Protective role of the lymphatics from sepsis
HEMATOPOIESIS & STEM CELLS
New insights into HIV impact on hematopoiesis
Ramesh Akkina
View Articletitled, New insights into HIV impact on hematopoiesis
INSIDE BLOOD
Shaping oncogenic NF-κB activity in the nucleus
Daniel Krappmann
View Articletitled, Shaping oncogenic NF-<strong>κ</strong>B activity in the nucleus

BLOOD WORK

Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia
Qin Huang
View Articletitled, Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia
Hemophagocytosis in a patient with persistent chronic lymphocytic leukemia
Elham Kamangar,Weiqiang Zhao
View Articletitled, Hemophagocytosis in a patient with persistent chronic lymphocytic leukemia

PLENARY PAPER

Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes
Jeon Yeob Jang,Young Jun Koh,Seung-Hun Lee,Junyeop Lee,Kyoo Hyun Kim,Daesoo Kim,Gou Young Koh,Ook Joon Yoo
View Articletitled, Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes
Supplemental data

BLOOD SPOTLIGHT

Congenital dyserythropoietic anemias: molecular insights and diagnostic approach
Achille Iolascon,Hermann Heimpel,Anders Wahlin,Hannah Tamary
View Articletitled, Congenital dyserythropoietic anemias: molecular insights and diagnostic approach

REVIEW ARTICLE

JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
Wolfgang Warsch,Christoph Walz,Veronika Sexl
View Articletitled, JAK of all trades: JAK2-STAT5 as novel therapeutic targets in <em>BCR-ABL1</em><sup><em>+</em></sup> chronic myeloid leukemia

REVIEW SERIES

Myeloproliferative neoplasms and thrombosis
Tiziano Barbui,Guido Finazzi,Anna Falanga
View Articletitled, Myeloproliferative neoplasms and thrombosis

CLINICAL TRIALS AND OBSERVATIONS

Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
Clinical Trials & Observations
Andreas S. Baur,Manfred B. Lutz,Stephan Schierer,Luca Beltrame,Gabi Theiner,Elisabeth Zinser,Christian Ostalecki,Gordon Heidkamp,Ina Haendle,Michael Erdmann,Manuel Wiesinger,Waltraud Leisgang,Stefanie Gross,Ansgar J. Pommer,Eckhart Kämpgen,Diana Dudziak,Alexander Steinkasserer,Duccio Cavalieri,Beatrice Schuler-Thurner,Gerold Schuler
View Articletitled, Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting T<sub>reg</sub>
Supplemental data

HEMATOPOIESIS AND STEM CELLS

HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice
Christopher C. Nixon,Dimitrios N. Vatakis,Scott N. Reichelderfer,Dhaval Dixit,Sohn G. Kim,Christel H. Uittenbogaart,Jerome A. Zack
View Articletitled, HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice
Supplemental data

IMMUNOBIOLOGY

Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans
Liset Westera,Julia Drylewicz,Ineke den Braber,Tendai Mugwagwa,Iris van der Maas,Lydia Kwast,Thomas Volman,Elise H. R. van de Weg-Schrijver,István Bartha,Gerrit Spierenburg,Koos Gaiser,Mariëtte T. Ackermans,Becca Asquith,Rob J. de Boer,Kiki Tesselaar,José A. M. Borghans
View Articletitled, Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans
Supplemental data
Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells
Jorieke H. Peters,Hans J. P. M. Koenen,Esther Fasse,Henk J. Tijssen,Jan N. M. IJzermans,Patricia J. T. A. Groenen,Nicolaas P. M. Schaap,Jaap Kwekkeboom,Irma Joosten
View Articletitled, Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells
Supplemental data
PARP-1 regulates expression of TGF-β receptors in T cells
Pin Zhang,Hiroko Nakatsukasa,Eric Tu,Shimpei Kasagi,Kairong Cui,Masaki Ishikawa,Joanne E. Konkel,Takashi Maruyama,Gang Wei,Brittany Abbatiello,Zhao-Qi Wang,Keji Zhao,WanJun Chen
View Articletitled, PARP-1 regulates expression of TGF-β receptors in T cells
Supplemental data

LYMPHOID NEOPLASIA

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma
Paola Bonetti,Monica Testoni,Marta Scandurra,Maurilio Ponzoni,Roberto Piva,Afua A. Mensah,Andrea Rinaldi,Ivo Kwee,Maria Grazia Tibiletti,Javeed Iqbal,Timothy C. Greiner,Wing-Chung Chan,Gianluca Gaidano,Miguel A. Piris,Franco Cavalli,Emanuele Zucca,Giorgio Inghirami,Francesco Bertoni
View Articletitled, Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma
Supplemental data
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Hendrik Nogai,Sören-Sebastian Wenzel,Stephan Hailfinger,Michael Grau,Eva Kaergel,Volkhard Seitz,Brigitte Wollert-Wulf,Matthias Pfeifer,Annette Wolf,Mareike Frick,Kerstin Dietze,Hannelore Madle,Alexander Tzankov,Michael Hummel,Bernd Dörken,Claus Scheidereit,Martin Janz,Peter Lenz,Margot Thome,Georg Lenz
View Articletitled, IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Supplemental data

TRANSPLANTATION

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease
Anandharaman Veerapathran,Joseph Pidala,Francisca Beato,Brian Betts,Jongphil Kim,Joel G. Turner,Marc K. Hellerstein,Xue-Zhong Yu,William Janssen,Claudio Anasetti
View Articletitled, Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease
Supplemental data
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia
Giorgio La Nasa,Giovanni Caocci,Fabio Efficace,Carlo Dessì,Adriana Vacca,Eugenia Piras,Marco Sanna,Michela Marcias,Roberto Littera,Carlo Carcassi,Guido Lucarelli
View Articletitled, Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

VASCULAR BIOLOGY

Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage
Maria Iolyeva,David Aebischer,Steven T. Proulx,Ann-Helen Willrodt,Tatiana Ecoiffier,Simone Häner,Grégory Bouchaud,Carsten Krieg,Lucas Onder,Burkhard Ludewig,Laura Santambrogio,Onur Boyman,Lu Chen,Daniela Finke,Cornelia Halin
View Articletitled, Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage
Supplemental data

CORRESPONDENCE

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals
Christina Psomas,Jean-Philippe Lavigne,Claudine Barbuat,Selma Trabelsi,Jade Ghosn,Caroline Lascoux-Combe,Philippe Flandre,Lise Cuzin,Jacques Reynes,Brigitte Autran,Pierre Corbeau
View Articletitled, Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals
Response: maraviroc intensification and microbial translocation
Peter W. Hunt,Michael M. Lederman,Steven G. Deeks
View Articletitled, Response: maraviroc intensification and microbial translocation
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
Marzia Varettoni,Silvia Zibellini,Luca Arcaini,Emanuela Boveri,Sara Rattotti,Cristiana Pascutto,Silvia Mangiacavalli,Manuel Gotti,Lara Pochintesta,Marco Paulli,Mario Cazzola
View Articletitled, MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Valeria Santini,Jennifer Schemenau,Alessandro Levis,Enrico Balleari,Rosa Sapena,Lionel Adès,Agnès Guerci,Odile Beyne-Rauzy,Marie-Pierre Gourin,Stephane Cheze,Aspasia Stamatoullas,Alessandro Sanna,Daniela Gioia,Gianni Cametti,Dario Ferrero,Emmanuel Raffoux,Christian Rose,Antonella Poloni,Thomas Prebet,Laurence Legros,Shanti Natarajan-Amé,Pierre Fenaux,Ulrich Germing,François Dreyfus,Sophie Park
View Articletitled, Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Impact of lead intoxication in children with iron deficiency anemia in low- and middle-income countries
Akshat Jain,Lawrence C. Wolfe,Ginee Jain
View Articletitled, Impact of lead intoxication in children with iron deficiency anemia in low- and middle-income countries
Iron deficiency anemia in low- and middle-income countries
Guillermo J. Ruiz-Argüelles
View Articletitled, Iron deficiency anemia in low- and middle-income countries

ERRATA

Soderquest K, Powell N, Luci C, et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood. 2011;117(17):4511-4518.
View Articletitled, Soderquest K, Powell N, Luci C, et al. Monocytes control natural killer cell differentiation to effector phenotypes. <em>Blood</em>. 2011;117(17):<span class="related-article">4511-4518</span>.
Stefater JA III, Rao S, Bezold K, et al. Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair. Blood. 2013;121(13):2574-2578.
View Articletitled, Stefater JA III, Rao S, Bezold K, et al. Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair. <em>Blood</em>. 2013;121(13):<span class="related-article">2574-2578</span>.
All Issues

Advertisement intended for health care professionals

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals